Commure vs Glooko
Side-by-side comparison of AI visibility scores, market position, and capabilities
$200M funding 2025; $200M+ ARR (doubled 3 consecutive years); $6B valuation (merged Athelas); 130+ health systems; HCA partnership; acquired Augmedix $139M/Memora; healthcare RCM leader
About
Commure is a healthcare infrastructure company founded to modernize the operational and clinical technology layer of health systems, which have historically relied on fragmented, decades-old software systems for workflows ranging from patient communication to revenue cycle management. The company was co-founded by Tanay Tandon and emerged from General Catalyst's health system subsidiary model, which provides capital and technology directly to large hospital networks. Commure merged with Athelas — an AI-powered revenue cycle management company — in 2023, combining Athelas's proven RCM automation with Commure's broader health system workflow platform to create a more comprehensive enterprise offering.\n\nCommure's platform addresses operational challenges across the health system enterprise including clinical documentation, ambient AI scribing through its Commure Scribe product, revenue cycle automation, patient engagement, and care team communication. The acquisition of Augmedix in 2024 added a leading ambient clinical intelligence capability, enabling physicians to automatically generate clinical notes from patient encounters using AI. Commure serves 130+ health systems and counts HCA Healthcare — one of the largest for-profit hospital networks in the US — as a strategic partner, providing both market validation and scale distribution for its products.\n\nCommure has achieved $200 million+ in annual recurring revenue, doubling for three consecutive years — a growth trajectory that has pushed its valuation to approximately $6 billion. The company's model of embedding deeply within health system operations, rather than selling point solutions that compete at the application layer, creates high switching costs and durable revenue streams. As health systems face intensifying margin pressure and clinician burnout driven by administrative overhead, Commure's AI-driven automation of clinical and operational workflows addresses two of the most urgent priorities simultaneously.
Glooko is a digital health platform for diabetes and chronic condition management; syncs data from 250+ glucose meters, CGMs, insulin pumps, and wearables; supports remote patient monitoring for clinicians and health systems; raised $100M+;
About
Glooko is a digital health company founded in 2010 and headquartered in Palo Alto, California, that provides a comprehensive platform for diabetes and chronic condition management. The company's technology aggregates data from over 250 connected diabetes devices — including continuous glucose monitors (CGMs), blood glucose meters, insulin pumps, pens, and health wearables — into a single unified platform that serves both patients and their care teams. For patients, Glooko provides a mobile app offering personalized insights, trend analysis, and education based on their glucose, insulin, activity, and nutrition data. For healthcare providers and clinical teams, Glooko's Population Health platform enables remote patient monitoring — allowing endocrinologists, diabetes educators, and primary care physicians to track patient cohorts, identify high-risk individuals, and deliver data-driven care interventions at scale.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.